Go Deep
Indoco Remedies Limited
Indoco Remedies Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,987 | 352.2 | 2.45 | 1.17 | 250.05 |
| Oct 2026 | 21,840 | 354.6 | 2.47 | 1.17 | 251.75 |
| Oct 2026 | 21,113 | 720.9 | 2.26 | 1.17 | 230.70 |
Indoco Remedies Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 4,662,200,000.0 | 4,559,000,000.0 | 4,343,400,000.0 | 4,718,300,000.0 |
| Net Profit | 649,900,000.0 | -216,400,000.0 | -297,900,000.0 | -79,300,000.0 |
| EPS | 7.1 | -2.6 | -3.2 | -1.0 |
Indoco Remedies Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 17,929,400,000.0 | 16,412,900,000.0 | 17,882,155,000.0 | 16,400,480,000.0 | — |
| Net Profit | -951,500,000.0 | -737,400,000.0 | 984,601,000.0 | 1,422,515,000.0 | — |
| EPS | -10.3 | -8.0 | 10.7 | 15.4 | — |
Indoco Remedies Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 25,932,700,000.0 | 24,299,136,000.0 | 21,447,285,000.0 | 16,581,984,000.0 | — |
| Total Liabilities | 16,611,600,000.0 | 14,115,351,000.0 | 10,342,319,000.0 | 6,299,468,000.0 | — |
| Total Equity | 9,392,800,000.0 | 10,219,964,000.0 | 11,099,001,000.0 | 10,282,516,000.0 | — |
Owes vs Owns
Indoco Remedies Limited owed ₹0.64 for every ₹1 it owned in Mar 2026, up from ₹0.38 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.64× | 0.58× | 0.48× | 0.38× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Indoco Remedies Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.8%Receivables 18.9%Inventory 15.6%Fixed assets (tangible) 41.7%Intangible assets 7.7%Long-term investments 0.6%Other assets 13.7%
How it's funded — Mar 2026
Short-term debt 20.0%Long-term debt 19.9%Payables 11.9%Other liabilities 12.2%Shareholders' equity 35.9%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 45.8 | 15.3 | 25.6 | 14.9 |
| Receivables | 489.2 | 352.4 | 406.2 | 350.9 |
| Inventory | 405.2 | 419.4 | 353.1 | 326.0 |
| Fixed assets (tangible) | 1,082.2 | 1,213.1 | 979.3 | 706.3 |
| Intangible assets | 200.9 | 192.2 | 188.0 | 124.3 |
| Long-term investments | 14.6 | 6.1 | 6.6 | 1.5 |
| Other assets | 355.4 | 231.4 | 186.0 | 134.3 |
| Liabilities & equity | ||||
| Short-term debt | 519.8 | 444.8 | 303.4 | 171.0 |
| Long-term debt | 516.0 | 533.2 | 351.7 | 143.5 |
| Payables | 308.5 | 208.1 | 153.6 | 123.5 |
| Other liabilities | 316.8 | 225.4 | 225.4 | 192.0 |
| Shareholders' equity | 932.1 | 1,018.4 | 1,110.5 | 1,028.3 |
| Net tangible assets | 738.4 | 829.8 | 921.9 | 904.0 |
Indoco Remedies Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,263,500,000.0 | 907,600,000.0 | 1,553,871,000.0 | 1,788,279,000.0 | — |
| Investing Activities | -873,800,000.0 | -2,597,900,000.0 | -4,325,153,000.0 | -2,081,724,000.0 | — |
| Financing Activities | -1,330,900,000.0 | 1,686,200,000.0 | 1,223,900,000.0 | 228,040,000.0 | — |